Published in Kansenshogaku Zasshi on January 01, 2004
Varicella zoster infection: a rare cause of abdominal pain mimicking acute abdomen. J Clin Med Res (2009) 0.79
Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis (2017) 0.75
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood (2005) 6.16
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci U S A (2010) 2.24
Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol (2007) 1.90
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun (2006) 1.79
Infliximab induces potent anti-inflammatory responses by outside-to-inside signals through transmembrane TNF-alpha. Gastroenterology (2005) 1.66
Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum (2006) 1.56
Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Cancer Res (2009) 1.55
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. Blood (2011) 1.54
Subdural spinal granuloma resulting from Candida albicans without immunosufficiency: case report. Spine (Phila Pa 1976) (2002) 1.38
Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood (2005) 1.37
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer (2002) 1.26
Patients' identification and reporting of unsafe events at six hospitals in Japan. Jt Comm J Qual Patient Saf (2011) 1.21
Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica (2007) 1.21
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis. Int J Hematol (2003) 1.18
A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. J Mol Biol (2007) 1.14
Constitutive expression of SOCS3 confers resistance to IFN-alpha in chronic myelogenous leukemia cells. Blood (2002) 1.13
Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood (2005) 1.10
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum (2003) 1.10
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood (2011) 1.10
Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway. J Immunol (2002) 1.10
Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol (2005) 1.09
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia. Blood (2008) 1.09
Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum (2005) 1.09
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues. Cancer Immunol Immunother (2002) 1.08
Development and applicability of Hospital Survey on Patient Safety Culture (HSOPS) in Japan. BMC Health Serv Res (2011) 1.07
Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun (2005) 1.07
HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol (2009) 1.00
Cost of illness of the stomach cancer in Japan - a time trend and future projections. BMC Health Serv Res (2013) 1.00
Peroxisome proliferator-activated receptor α and γ agonists together with TGF-β convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells. J Immunol (2010) 0.96
Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Cancer Immunol Immunother (2011) 0.96
The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma. Leuk Lymphoma (2004) 0.96
Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. Br J Haematol (2003) 0.95
Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosomes Cancer (2005) 0.95
The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation. J Biol Chem (2008) 0.95
Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J Virol (2002) 0.95
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. Blood (2013) 0.93
WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases. Microbiol Immunol (2004) 0.90
Human cord blood- and bone marrow-derived CD34+ cells regenerate gastrointestinal epithelial cells. FASEB J (2004) 0.90
Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice. Arthritis Res Ther (2007) 0.90
A novel fusion variant of the MORF and CBP genes detected in therapy-related myelodysplastic syndrome with t(10;16)(q22;p13). Br J Haematol (2003) 0.89
Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor. PLoS One (2013) 0.89
Maximum standard uptake value of 18F-fluorodeoxyglucose positron emission tomography is a prognostic factor for progression-free survival of newly diagnosed patients with diffuse large B cell lymphoma. Ann Hematol (2012) 0.89
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma. Int J Hematol (2007) 0.89
Cooperative role of the membrane-proximal and -distal residues of the integrin beta3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta3 activation. J Biol Chem (2008) 0.89
A new four-way variant t(5;17;15;20)(q33;q12;q22;q11.2) in acute promyelocytic leukemia. Int J Hematol (2011) 0.88
Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes. Exp Hematol (2005) 0.88
Myeloma cells are highly sensitive to the granule exocytosis pathway mediated by WT1-specific cytotoxic T lymphocytes. Clin Cancer Res (2004) 0.87
[A Fatal Case of Severe Fever with Thrombocytopenia Syndrome Complicated by Hemophagocytic Lymphohistiocytosis]. Kansenshogaku Zasshi (2015) 0.87
Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner. Blood (2005) 0.87
Probucol delays progression of diabetic nephropathy. Diabetes Res Clin Pract (2005) 0.87
Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha. Leuk Res (2005) 0.86
Human cord blood--derived cells generate insulin-producing cells in vivo. Stem Cells (2005) 0.86
Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. J Immunother (2007) 0.85
Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLoS One (2010) 0.85
Transcriptional downregulation of DC-SIGN in human herpesvirus 6-infected dendritic cells. J Gen Virol (2004) 0.85
IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum (2006) 0.85
Identification of critical residues for ligand binding in the integrin beta3 I-domain by site-directed mutagenesis. Thromb Haemost (2002) 0.85
Human herpesvirus 6 impairs differentiation of monocytes to dendritic cells. Exp Hematol (2006) 0.84
Hypocellular acute promyelocytic leukemia with a tetraploid clone characterized by two t(15;17). Cancer Genet Cytogenet (2003) 0.84
Mutations of syntaxin 11 and SNAP23 genes as causes of familial hemophagocytic lymphohistiocytosis were not found in Japanese people. J Hum Genet (2005) 0.84
Protein kinase C inhibitor generates stable human tolerogenic dendritic cells. J Immunol (2013) 0.83
Behçet's disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines. Mod Rheumatol (2003) 0.83
Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol (2003) 0.83
Human herpesvirus 6 infection impairs Toll-like receptor signaling. Virol J (2010) 0.83
Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy. Br J Haematol (2003) 0.82
Antilung cancer effect of WT1-specific cytotoxic T lymphocytes. Clin Cancer Res (2002) 0.82
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression. Mol Ther Nucleic Acids (2012) 0.82
Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia. J Atheroscler Thromb (2004) 0.81
Derivative (1;18)(q10;q10) in essential thrombocythemia. Cancer Genet Cytogenet (2010) 0.81
Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome. Am J Hematol (2009) 0.81
Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit (2007) 0.81
Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia. Expert Opin Ther Targets (2009) 0.81
Surgical management of axillary necrotizing fasciitis: a case report. J Dermatol (2011) 0.81
Abacavir/lamivudine versus tenofovir/emtricitabine with atazanavir/ritonavir for treatment-naive Japanese patients with HIV-1 infection: a randomized multicenter trial. Intern Med (2013) 0.81
Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes. Br J Haematol (2002) 0.81
Existence of leukemic clones resistant to both imatinib mesylate and rituximab before drug therapies in a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Int J Hematol (2004) 0.81
Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia. J Biomed Biotechnol (2010) 0.81
Follicular dendritic cell tumor as an unknown primary tumor. Int J Clin Oncol (2007) 0.81
Severe fever with thrombocytopenia syndrome mimicking intravascular lymphoma. Rinsho Ketsueki (2015) 0.80
Secondary amyloidosis and eosinophilia in a patient with uterine leiomyosarcoma. Jpn J Clin Oncol (2005) 0.80
Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer. Expert Opin Biol Ther (2011) 0.80
Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Int J Hematol (2007) 0.80